APR 18, 2024
How Effective Is Anti-ANG2 and Anti-VEGF for Neovascular AMD With Persistent Epithelial Defects?
Retina Subspecialty Day 2023
Retina/Vitreous
In this presentation from Retina Subspecialty Day 2023, Dr. Lim presents the findings from the study that compared the effectiveness of anti-ANG2 versus anti-VEGF in patients with neovascular AMD with PED.